CAH vs REPL · P/E 35, rev $222.58B vs $825.7M cap
Cardinal Health Inc (CAH) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
Cardinal Health Inc (CAH) is a medical distribution company listed on NYSE.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported CAH revenue for 2025-06-30 was $222.58B. Net income was $1.57B. Revenue was down 1.9% from 2024-06-30 to 2025-06-30. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
REPL does not have a complete income-statement cache yet.
CAH currently screens at market cap $53.00B and trailing P/E 34.6. REPL currently screens at market cap $825.7M.
Not investment advice. Open the CAH and REPL stock pages for the full models.
Not investment advice.